CPT1B and gastric cancer: Another study found that highly expressed guanylate cyclase-binding membrane receptor NPRA bound to PPARα and prevented PPARα degradation, and under the protection of NPRA, the expression of PPARα was increased to activate CPT1B, which promoted fatty acid oxidation and malignant biological behavior of gastric cancer cells [98].